Results 151 to 160 of about 61,637 (294)

Factors influencing seizure induction in patients with intracranial EEG recording

Epilepsia, EarlyView.
Abstract Objective To shorten inpatient epilepsy monitoring unit (EMU) stays during epilepsy surgery evaluation, physicians utilize techniques to induce seizures including antiseizure medication (ASM) reduction, sleep deprivation, and chemical stimulation. We assessed the relative efficacy of these techniques.
Hina Dave, Morgan McCreary, Antonio Guerra, Michael R. Sperling   +3 more
wiley   +1 more source

Comparative risk of major health events among individuals prescribed different antiseizure medications following ischemic stroke

Epilepsia, EarlyView.
Abstract Objective The aim of this study was to compare the risk of seizure, recurrent stroke, fall or fracture, and mortality in individuals prescribed different antiseizure medications (ASMs) following an ischemic stroke. Methods We identified all patients admitted to a Victorian public or private hospital with a principal diagnosis of an incident ...
Stella Jung‐Hyun Kim, Clara Marquina, Emma Foster, J. Simon Bell, Jenni Ilomäki   +4 more
wiley   +1 more source

Management of Refractory Catatonia Associated With OCD Exacerbation in a Patient With Bipolar I Disorder: A Case Report

Bipolar Disorders, EarlyView.
Jiyun Lee, Rahat Hossain, Nikola Grujich, Ayal Schaffer   +3 more
wiley   +1 more source

Variants in ATP6V0C are associated with Dravet‐like developmental and epileptic encephalopathy

Epilepsia, EarlyView.
Abstract Objective Dravet syndrome (DS) is a developmental and epileptic encephalopathy. Diagnosis is clinical, but ~90% of patients have pathogenic variants in SCN1A. ATP6V0C has recently been proposed as a novel candidate gene for epilepsy, with or without developmental delay.
Marlene Rong, Paula T. Marques, Quratulain Zulfiqar Ali, Ricardo Morcos, Ilakkiah Chandran, Farah Qaiser, Rikke S. Møller, Allan Bayat, Guido Rubboli, Elena Gardella, Miriam S. Reuter, Tristan T. Sands, Ingrid E. Scheffer, Amy Schneider, Annapurna Poduri, Elaine Wirrell, Rima Nabbout, Joseph Sullivan, Kette Valente, Stéphane Auvin, Kelly G. Knupp, Andreas Brunklaus, Ángel Aledo‐Serrano, Danielle M. Andrade   +23 more
wiley   +1 more source

Carbamazepine-Induced Oral Lichenoid Reaction: A Report of a Rare Case. [PDF]

Cureus
Cinar G, Metin A.
europepmc   +1 more source

Bioaccumulation and bioconcentration of carbamazepine and other pharmaceuticals in fish under field and controlled laboratory experiments. Evidences of carbamazepine metabolization by fish.

Science of the Total Environment, 2016
M. Valdés, B. Huerta, D. Wunderlin, M. Bistoni, D. Barceló, D. Barceló, S. Rodríguez-Mozaz   +6 more
semanticscholar   +1 more source

Epilepsy–heart syndrome: Concept, clinical context, and opportunity for integrated care

Epilepsia, EarlyView.
Abstract In this concept paper, we introduce epilepsy‐heart syndrome as a shared burden of illness between epilepsy and cardiac disorders. This pragmatic definition is agnostic of which condition came first (the epilepsy or the cardiac disorder), recognising that these conditions can each serve as a risk factor for the other owing to a bidirectional ...
Gashirai K. Mbizvo, Iain E. Buchan, Anthony G. Marson, Gregory Y. H. Lip   +3 more
wiley   +1 more source

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers. [PDF]

Front Pharmacol
Lenard A, Hermann SA, Stoll F, Burhenne J, Foerster KI, Czock D, Mikus G, Meid AD, Haefeli WE, Blank A.   +9 more
europepmc   +1 more source

Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the BLESS study

Epilepsia, EarlyView.
Abstract Objective Cenobamate is an antiseizure medication (ASM) with a dual mechanism of action that was recently approved for the treatment of focal seizures in adults. This analysis aimed to describe the outcomes at 12 and 24 weeks after starting cenobamate therapy in a real‐world setting.
Simona Lattanzi, Fedele Dono, Giuseppe d'Orsi, Alfredo D'Aniello, Mariangela Panebianco, Paolo Bonanni, Carlo Di Bonaventura, Elisa Montalenti, Antonio Gambardella, Federica Ranzato, Giada Pauletto, Elena Tartara, Angela La Neve, Francesca Bisulli, Giampaolo Vatti, Patrizia Pulitano, Claudio Liguori, Giovanni Assenza, Alfonso Giordano, Pietro Pignatta, Vincenzo Belcastro, Michela Cecconi, Simone Beretta, Chiara Pizzanelli, Marianna Pezzella, Massimo Gangitano, Maurizio Elia, Rosaria Renna, Catello Vollono, Angelo Pascarella, Luciana Tramacere, Giovanni De Maria, Daniela Audenino, Maria Pia Pasolini, Loretta Giuliano, Rosita Galli, Gionata Strigaro, Monica Puligheddu, Angelo Labate, Pietro Penza, Stefano Quadri, David Stokelj, Giovanni Boero, Elisa Fallica, Monica Santo Sabato, Giovanni Falcicchio, Nicoletta Foschi, Michela Procaccini, Valentina Villano, Gabriele Camattari, Fabiano Mele, Barbara Roncari, Giancarlo Di Gennaro, the BLESS Study Group   +53 more
wiley   +1 more source

Carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy

Epilepsia, 2017
B. Berghuis, J. van der Palen, G. de Haan, D. Lindhout, B. Koeleman, Josemir W Sander   +5 more
semanticscholar   +1 more source